Extractables & Leachables for Injectable Formulations
Extractables and leachables can compromise the safety and efficacy of injectable formulations and are therefore subject to regulatory scrutiny. This webinar examines the studies that need to be performed for FDA submissions, an integral part of the regulatory approval process, outlining regulatory expectations in this area. Current PQRI (Product Quality Research Group) safety thresholds for injectable products are also considered. Effective extractable and leachables workflows are presented that can derisk and accelerate product development and the issue of risk assessment is discussed. Advice is given on overcoming certain common problems associated with extractable and leachables and Aptar Pharma’s expertise and services in this area are introduced.
Speaker(s): Julie D. Suman Scott Toth
19 Oct 2021
Subscribe to Email Updates
Submit your email address below and stay up to date with the latest industry insights.
*Required. For details about how your email address will be used, read our General Terms and Conditions of Use, Privacy and Cookies Policy.
Requesting access to Extractables & Leachables for Injectable Formulations.